University of Ljubljana
million € in market revenue
New immunostimulants as vaccine adjuvants and drugs for the immunotherapy of cancer and infectious diseases
Our specification refers to novel conjugated compounds that function as immunostimulants and are useful for the treatment of viral, bacterial, fungal and protozoal infections, tumours or cancers and other immunological diseases. Additionally, the conjugated compounds of the invention can be used as vaccine adjuvants….
Nitroxoline for prevention and treatment of coronavirus disease
The advantage of nitroxoline over other candidate drugs for the treatment of Covid 19 (repurposing drugs – amantadine, teicoplanin) is that the mechanism of action on the target is precisely defined, since years ago we determined the spatial structure of the complex with cathepsin B….